NCT07796984

Brief Summary

As part of the clinical management of certain severe, drug-resistant forms of epilepsy, it is necessary to implant electrodes in the brain to identify the epileptic network prior to potential neurosurgical resection of the source zones. This standardized procedure, known as Stereo-Electroencephalography (SEEG), was developed in France in the 1960s. The electrodes remain implanted for several days-typically two weeks-while awaiting spontaneous epileptic seizures. During this period, the patient remains hospitalized, and their electroencephalographic activity is recorded around the clock. Patients can be asked to perform cognitive tasks (such as tasks involving memory, attention, vision, language, and decision-making) while awake or asleep; the results can then be correlated with the intracerebral electroencephalographic activity recorded simultaneously as part of their clinical care. This approach makes it possible to capture the electrophysiological signatures of specific cognitive processes, thereby enabling researchers to: 1) create a brain map of electrophysiological signatures, 2) improve standard models of cognitive function, and 3) study the dysfunction of these processes in epilepsy.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
62mo left

Started Oct 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 1, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2031

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2031

Last Updated

September 1, 2026

Status Verified

August 1, 2026

Enrollment Period

5 years

First QC Date

August 27, 2026

Last Update Submit

August 27, 2026

Conditions

Keywords

epilepsycognitive taskstereoelectroencephalography

Outcome Measures

Primary Outcomes (1)

  • Construction of a database of electrophysiological signatures of various cognitive functions

    Correlation of performance on a task involving a neurocognitive process with characteristics of brain activity recorded during the task (electrophysiological signature) using intracranial stereo-electroencephalography (SEEG) electrodes.

    3 weeks after the inclusion

Secondary Outcomes (2)

  • Evaluation of the impact of epilepsy on these electrophysiological signatures

    3 weeks after the inclusion

  • Determine whether a given brain region is dysfunctional in certain epileptic patients by comparing it with the atlas of normal physiological signatures.

    3 weeks after the inclusion

Study Arms (1)

Patients hospitalized for SEEG with cognitive tasks

Other: Cognitive tasks in the form of questionnaires

Interventions

During their hospitalization for SEEG, patients will perform cognitive tasks to assess memory, vision, attention, language, and decision-making.

Patients hospitalized for SEEG with cognitive tasks

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with drug-resistant epilepsy hospitalized for stereo-electroencephalography

You may qualify if:

  • Patient with drug-resistant focal epilepsy undergoing SEEG evaluation as part of the pre-surgical workup for epilepsy
  • Intellectual capacity sufficient to perform cognitive tasks, receive information about the study procedure, and understand the information sheet

You may not qualify if:

  • Patients already participating in another research project that prohibits participation in another study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Electrophysiologie cérébrale, épilepsie, sommeil, Hôpital Pierre Paul Riquet

Toulouse, Oui, 31000, France

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Jonathan Curot, PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2026

First Posted

September 1, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

October 1, 2031

Study Completion (Estimated)

October 31, 2031

Last Updated

September 1, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations